发明名称 |
PROCESS FOR ASSESSING RISK OF SUBSTANCE ADMINISTRATION |
摘要 |
A process for assessing risk that administration of a substance will suppress immune competence in a population of subjects is provided. Such a substance may be a substance related to, contained in or derived from a tobacco product or, more generally, a substance concerning which it is desired to assess risk of administration of the substance. |
申请公布号 |
US2016025705(A1) |
申请公布日期 |
2016.01.28 |
申请号 |
US201514796091 |
申请日期 |
2015.07.10 |
申请人 |
R.J. Reynolds Tobacco Company |
发明人 |
PRASAD GADDAMANUGU L.;Arimilli Subhashini |
分类号 |
G01N33/50 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
1. A process for assessing risk that administration of a substance will suppress immune competence in a population of subjects, the process comprising:
collecting a sample of blood from each a plurality of subjects, said subjects being members of the population; isolating peripheral blood mononuclear cells (PBMCs) from the sample of blood to form isolated PBMCs; administering the substance to the isolated PBMCs, thereby forming substance-exposed PBMCs; stimulating the substance-exposed PBMCs with a Toll-like receptor ligand to form Toll-like receptor-ligand stimulated substance-exposed PBMCs; measuring one or more responses of effector cells in the Toll-like receptor-ligand stimulated substance-exposed PBMCs to form one or more measured responses; aggregating the one or more measured responses from each of the plurality of subjects to form one or more response aggregates; comparing the one or more response aggregates to one or more immune-competence-associated reference ranges,thereby assessing risk that administration of the substance will suppress immune competence in the population of subjects. |
地址 |
Winston-Salem NC US |